Sign in to view content

Suprachoroidal Delivery of Investigational ABBV-RGX-314 for Diabetic Retinopathy: The Phase II ALTITUDE® Study

Margaret A. Chang, MD, MS

Video
Published 2025

Related

New Tool for Predicting the 3-Year Risk of Vision-Threatening Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
Bobeck S Modjtahedi, MD
Annual Meeting Talks
2022
Post Hoc Analysis of Suprachoroidal Injection Experience Across Retinal Disease Indications
Christopher R Henry, MD
Annual Meeting Talks
2020
Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022

Category: Diabetic Retinopathy

See more